Flucelvax Trivalent 2024-2025 is an injectable vaccine that protects towards three strains of the influenza virus. It’s authorised to be used in individuals 6 months of age and older.
Flucelvax Trivalent 2024-2025 is made utilizing a cell culture-based manufacturing methodology. Which means the vaccine is produced in a managed atmosphere utilizing mammalian cells. This methodology is extra environment friendly and cheaper than conventional egg-based manufacturing strategies.
Flucelvax Trivalent 2024-2025 has been proven to be secure and efficient in scientific trials. It’s well-tolerated, with the commonest unwanted effects being injection web site ache, redness, and swelling.
